AI Article Synopsis
- This case report examines the effects of a controlled-release dexamethasone implant (Ozurdex) on a patient with cancer-associated retinopathy.
- The evaluation of the patient's anatomical results used spectral domain optical coherence tomography, while functional outcomes were measured through visual acuity, microperimetry, and multifocal electroretinography.
- The follow-up period for assessing these outcomes lasted for 1 year.
Article Abstract
This case report aims to show the anatomical and functional results of a patient diagnosed as having cancer-associated retinopathy treated with a controlled-release dexamethasone implant (Ozurdex). Anatomical outcomes were assessed using spectral domain optical coherence tomography; and functional outcomes, by measuring visual acuity, microperimetry, and mutifocal electroretinography. The follow-up period was 1 year.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5935/0004-2749.20230006 | DOI Listing |
Publication Analysis
Top Keywords
dexamethasone implant
8
cancer-associated retinopathy
8
slow-release dexamethasone
4
implant cancer-associated
4
retinopathy case
4
case report
4
report aims
4
aims anatomical
4
anatomical functional
4
functional patient
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!